(Q34884492)

English

Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

0 references

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

author name string

Merche Prats

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Ramon Font

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Carmen García

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Carmen Cabré

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Manel Jariod

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Alberto Martinez Vea

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

31 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

167

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

31 July 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

FGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Intact fibroblast growth factor 23 and fragments in plasma from Gambian children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Mechanism of FGF23 processing in fibrous dysplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Clinical use of intravenous iron: administration, efficacy, and safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Iron supplementation to treat anemia in patients with chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Bone formation regulates circulating concentrations of fibroblast growth factor 23.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Excess iron inhibits osteoblast metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Ferric carboxymaltose: a review of its use in iron-deficiency anaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Clinical aspects of iron use in the anemia of kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Parenteral iron nephrotoxicity: potential mechanisms and consequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

8 July 2018

Iron status and hemoglobin level in chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-14-167

21 January 2018

Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-14-167

21 January 2018

Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-14-167

21 January 2018

FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-14-167

21 January 2018

Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in rats

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-14-167

21 January 2018

Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-14-167

21 January 2018

Low molecular weight iron dextran increases fibroblast growth factor-23 concentration, together with parathyroid hormone decrease in hemodialyzed patients.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-14-167

21 January 2018

Iron infusion and deposition in the kidney

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-14-167

21 January 2018

Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-14-167

21 January 2018

The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-14-167

21 January 2018

Safety and tolerability of ferric carboxymaltose (FCM) for treatment of iron deficiency in patients with chronic kidney disease and in kidney transplant recipients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

26 October 2018

[Hereditary spherocytosis associated with severe hypophosphatemia in patients recovering from aplastic crisis]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751040

26 October 2018

Iron accumulation in human chronic renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity of Fibroblast Growth Factor 23 Measurements in Tumor-Induced Osteomalacia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dietary protein alters tubular iron accumulation after partial nephrectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in fibroblast growth factor 23 during treatment of secondary hyperparathyroidism with alfacalcidol or paricalcitol

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe hypophosphatemia during hematopoietic reconstitution after allogeneic peripheral blood stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of intravenous administration of iron preparations on the metabolism of phosphorus. Comparative study on 3 iron preparations

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of iron on FGF23-mediated Ca-P metabolism in CKD patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cefotetan-induced hemolytic anemia causing severe hypophosphatemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23902731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2369-14-167

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34884492&oldid=1955269206"